CH452517A - Verfahren zur Herstellung neuer Steroide - Google Patents

Verfahren zur Herstellung neuer Steroide

Info

Publication number
CH452517A
CH452517A CH988565A CH988565A CH452517A CH 452517 A CH452517 A CH 452517A CH 988565 A CH988565 A CH 988565A CH 988565 A CH988565 A CH 988565A CH 452517 A CH452517 A CH 452517A
Authority
CH
Switzerland
Prior art keywords
making new
new steroids
steroids
making
new
Prior art date
Application number
CH988565A
Other languages
English (en)
Inventor
Westerhof Pieter
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of CH452517A publication Critical patent/CH452517A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
CH988565A 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer Steroide CH452517A (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL226774 1958-04-12
NL232312 1958-10-15
NL236884 1959-03-07
NL237103 1959-03-13

Publications (1)

Publication Number Publication Date
CH452517A true CH452517A (de) 1968-03-15

Family

ID=27483655

Family Applications (3)

Application Number Title Priority Date Filing Date
CH7177159A CH398576A (de) 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer Steroide
CH988565A CH452517A (de) 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer Steroide
CH167165A CH396894A (de) 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer Steroide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH7177159A CH398576A (de) 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer Steroide

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH167165A CH396894A (de) 1958-04-12 1959-04-09 Verfahren zur Herstellung neuer Steroide

Country Status (2)

Country Link
CH (3) CH398576A (de)
GB (4) GB929275A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2994092B1 (fr) * 2012-08-03 2014-11-28 Centre Nat Rech Scient Nouveaux composes activateurs de l'activite enzymatique de sirt1 et compositions pharmaceutiques ou cosmetiques les comprenant

Also Published As

Publication number Publication date
GB929274A (en) 1963-06-19
GB929272A (en) 1963-06-19
GB929275A (en) 1963-06-19
CH396894A (de) 1965-08-15
GB929273A (en) 1963-06-19
CH398576A (de) 1966-03-15

Similar Documents

Publication Publication Date Title
CH382153A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH375005A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH432505A (de) Verfahren zur Herstellung neuer Steroide
CH374662A (de) Verfahren zur Herstellung neuer 6-Fluor-Steroide
CH375352A (de) Verfahren zur Herstellung neuer 6-Fluor-9a-halogensteroide
CH375353A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH382742A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH375003A (de) Verfahren zur Herstellung neuer 6-Fluor-Steroide
CH396895A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH376103A (de) Verfahren zur Herstellung von Steroidverbindungen
CH395987A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH381671A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH381672A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH396894A (de) Verfahren zur Herstellung neuer Steroide
CH388307A (de) Verfahren zur Herstellung neuer Steroide
CH378315A (de) Verfahren zur Herstellung neuer Steroide
CH389597A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH380117A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH397670A (de) Verfahren zur Herstellung neuer Steroidverbindungen
AT244000B (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH383959A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH383958A (de) Verfahren zur Herstellung neuer Steroidester
AT237201B (de) Verfahren zur Herstellung neuer, anabol wirksamer Steroide
CH388308A (de) Verfahren zur Herstellung neuer Steroidverbindungen
CH465600A (de) Verfahren zur Herstellung neuer Steroide